• Atox Bio Announces Chief Commercial Officer Appointment americanpharmaceuticalreview
    February 18, 2019
    Atox Bio announced the appointment of Robert Greif as Chief Commercial Officer. In this newly created position, Greif will be responsible for building the commercial organization and pre-commercial activities for Reltecimod....
PharmaSources Customer Service